Eladur transdur-bupivacaine: Phase IIb started

King began a double-blind, placebo-controlled Phase IIb trial to evaluate 3 Eladur patches administered every 72 hours for 12 weeks in 260 patients. King gained Eladur through its acquisition of Alph...